Zoetis ZTS
NYSE ZTS
$84.39 +0.57 (+0.68%)
At close: Nov 16, 2026 · 4:00 PM EST

Zoetis (ZTS) Income from Continuing Operations (2012 - 2026)

Updated

Zoetis' Income from Continuing Operations was $591 million in Q3 2026, down 18.0% from $721 million a year earlier and down 14.5% from the prior quarter.

Analysis

Zoetis (ZTS) Income from Continuing Operations (2012 - 2026) Analysis & Trends

On a trailing twelve-month basis, Zoetis' Income from Continuing Operations was $2.51 billion through Sep 30, 2026, down 4.7% year-over-year; for FY2025, it came in at $2.67 billion, up 7.1% from FY2024.

  • Income from Continuing Operations has now increased for ten consecutive years, with a five-year compound annual growth rate of 10.3% (FY2020 to FY2025).
  • In earlier years, Income from Continuing Operations was $2.5 billion in FY2024 (+6.7%), $2.34 billion in FY2023 (+10.8%), $2.11 billion in FY2022 (+3.8%) and $2.03 billion in FY2021 (+24.3%).
  • The Q3 2026 figure marks the lowest quarterly Income from Continuing Operations since Q4 2024.
  • Compared with a year earlier, Income from Continuing Operations has declined for three straight quarters, with growth averaging 2.1% over the last eight quarters.
  • The best year-over-year quarter for Income from Continuing Operations over five years was Q2 2023 (growth of 26.7%); the worst was Q3 2026 (a decline of 18.0%).
  • Per Business Quant data, ZTS's Income from Continuing Operations in the three quarters before Q3 2026 was $691 million (Q2 2026), $601 million (Q1 2026) and $624 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 6.45 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 210.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 4.22 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 5.07 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 4.80 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 3.86 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 2.43 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 3.25 Bn
10 Zoetis 34.65 Bn 27.05 Bn 1.69 Bn 591.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 591.00 Mn
Jun 30, 2026 691.00 Mn
Mar 31, 2026 601.00 Mn
Dec 31, 2025 624.00 Mn
Sep 30, 2025 721.00 Mn
Jun 30, 2025 726.00 Mn
Mar 31, 2025 602.00 Mn
Dec 31, 2024 581.00 Mn
Sep 30, 2024 692.00 Mn
Jun 30, 2024 624.00 Mn
Mar 31, 2024 599.00 Mn
Dec 31, 2023 523.00 Mn
Sep 30, 2023 596.00 Mn
Jun 30, 2023 670.00 Mn
Mar 31, 2023 551.00 Mn
Dec 31, 2022 460.00 Mn
Sep 30, 2022 528.00 Mn
Jun 30, 2022 529.00 Mn
Mar 31, 2022 594.00 Mn
Dec 31, 2021 413.00 Mn
API Access

Zoetis Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=ZTS&period=max&api_key=YOUR_API_KEY